Literature DB >> 24395435

Perinatal outcomes in type 2 diabetes.

Niranjala M Hewapathirana1, Helen R Murphy.   

Abstract

Over the past decade the prevalence of type 2 diabetes in pregnancy has continued to increase. It is vital that health care professionals recognize that preconception care is just as important for mothers with type 2 diabetes as it is in type 1 diabetes. All women with type 2 diabetes should be advised regarding safe effective contraception and the benefits of optimal glycemic control, folic acid supplementation, and avoidance of potentially harmful mediations before attempting pregnancy. Glycemic control is the most important modifiable risk factor for congenital anomaly in women with type 2 diabetes, whereas maternal obesity and social disadvantage are associated with large for gestational age neonates. This review aims to bring the reader up to date with the burden of perinatal outcomes and clinical interventions to improve maternal and infant health. It warns that the consequences of type 2 diabetes pregnancy do not end at birth.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24395435     DOI: 10.1007/s11892-013-0461-1

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  43 in total

Review 1.  Diabetes-induced birth defects: what do we know? What can we do?

Authors:  E Albert Reece
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

2.  Perinatal outcomes in type 2 diabetic patients compared with non-diabetic patients matched by body mass index.

Authors:  Kristin M Knight; Eva K Pressman; David N Hackney; Loralei L Thornburg
Journal:  J Matern Fetal Neonatal Med       Date:  2011-07-05

3.  Fetal growth profiles of macrosomic and non-macrosomic infants of women with pregestational or gestational diabetes.

Authors:  N M Hammoud; G H A Visser; S A E Peters; E M Graatsma; L Pistorius; H W de Valk
Journal:  Ultrasound Obstet Gynecol       Date:  2013-03-11       Impact factor: 7.299

4.  Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.

Authors:  Marc Foretz; Sophie Hébrard; Jocelyne Leclerc; Elham Zarrinpashneh; Maud Soty; Gilles Mithieux; Kei Sakamoto; Fabrizio Andreelli; Benoit Viollet
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

5.  Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study.

Authors:  Mary C M Macintosh; Kate M Fleming; Jaron A Bailey; Pat Doyle; Jo Modder; Dominique Acolet; Shona Golightly; Alison Miller
Journal:  BMJ       Date:  2006-06-16

Review 6.  Intergenerational transmission of insulin resistance and type 2 diabetes.

Authors:  Lucilla Poston
Journal:  Prog Biophys Mol Biol       Date:  2010-12-15       Impact factor: 3.667

7.  The pregnancies of women with Type 2 diabetes: poor outcomes but opportunities for improvement.

Authors:  J M Roland; H R Murphy; V Ball; J Northcote-Wright; R C Temple
Journal:  Diabet Med       Date:  2005-12       Impact factor: 4.359

8.  Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders.

Authors:  Paula Krakowiak; Cheryl K Walker; Andrew A Bremer; Alice S Baker; Sally Ozonoff; Robin L Hansen; Irva Hertz-Picciotto
Journal:  Pediatrics       Date:  2012-04-09       Impact factor: 7.124

9.  Glycemic control and pregnancy outcomes in women with type 2 diabetes from Poland. The impact of pregnancy planning and a comparison with type 1 diabetes subjects.

Authors:  Katarzyna Cyganek; Alicja Hebda-Szydlo; Jan Skupien; Barbara Katra; Izabela Janas; Alicja Borodako; Irena Kaim; Tomasz Klupa; Alfred Reron; Maciej T Malecki
Journal:  Endocrine       Date:  2011-04-29       Impact factor: 3.633

10.  Vitamin B12 and homocysteine status during pregnancy in the metformin in gestational diabetes trial: responses to maternal metformin compared with insulin treatment.

Authors:  K L Gatford; C M Houda; Z X Lu; S Coat; P A Baghurst; J A Owens; K Sikaris; J A Rowan; W M Hague
Journal:  Diabetes Obes Metab       Date:  2013-02-28       Impact factor: 6.577

View more
  2 in total

1.  Cord blood metabolic markers are strong mediators of the effect of maternal adiposity on fetal growth in pregnancies across the glucose tolerance spectrum: the PANDORA study.

Authors:  I-Lynn Lee; Elizabeth L M Barr; Danielle Longmore; Federica Barzi; Alex D H Brown; Christine Connors; Jacqueline A Boyle; Marie Kirkwood; Vanya Hampton; Michael Lynch; Zhong X Lu; Kerin O'Dea; Jeremy Oats; H David McIntyre; Paul Zimmet; Jonathan E Shaw; Louise J Maple-Brown
Journal:  Diabetologia       Date:  2020-01-08       Impact factor: 10.122

2.  Preconception care in Saudi women with diabetes mellitus.

Authors:  Amal Y Madanat; Eman A Sheshah
Journal:  J Family Community Med       Date:  2016 May-Aug
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.